(NEW YORK)Shares of some top pharmaceuticals companies were mixed at the close of trading: Bristol-Myers Squibb fell $.30 or 1.4 percent, to $21.34.READ MORE
(NEW YORK)Mylan Inc. said Friday it is immediately launching a generic version of the Alzheimer's disease drug Razadyne after receiving regulatory approval and a favorable court ruling.READ MORE